Table 3 – Health-related quality of life (EQ-5D) at baseline and during follow-up.

From: Sociodemographic factors and biologic therapy exposure impacting health-related quality of life in psoriatic arthritis - findings from a nationwide registry Reuma.pt

 

T0

n = 342

T1

n = 309

T2

n = 168

p-value

T0/T1

p-value

T0/T2

p-value

T1/T2

EQ-5D

      

 Mobility

      

 No problems

165 (48.3)

185 (59.9)

96 (57.1)

Ref.

Ref.

Ref.

 Some problems

175 (51.2)

120 (38.8)

71 (42.3)

< 0.001

0.021

0.303

 Extreme problems

2 (0.6)

4 (1.3)

1 (0.6)

   

Self-care

      

 No problems

227 (66.4)

225 (72.8)

118 (70.2)

Ref.

Ref.

Ref.

 Some problems

107 (31.3)

78 (25.2)

46 (27.4)

0.005

0.172

0.879

 Extreme problems

8 (2.3)

6 (1.9)

4 (2.4)

   

Usual activities

      

 No problems

149 (43.6)

159 (51.5)

89 (53.0)

Ref.

Ref.

Ref.

 Some problems

185 (54.1)

142 (46.0)

75 (44.6)

0.003

0.012

0.866

 Extreme problems

8 (2.3)

8 (2.6)

4 (2.4)

   

Pain/discomfort

      

 No pain or discomfort

71 (20.8)

95 (30.7)

45 (26.8)

Ref.

Ref.

Ref.

 Moderate pain or discomfort

244 (71.4)

198 (64.1)

117 (69.6)

< 0.001

0.009

0.343

 Extreme pain or discomfort

27 (7.9)

16 (5.2)

6 (3.4)

   

Anxiety/depression

      

 Not anxious or depressed

174 (50.9)

173 (56.0)

96 (57.1)

Ref.

Ref.

Ref.

 Moderately anxious or depressed

146 (42.7)

122 (39.5)

64 (38.1)

0.029

0.277

0.883

 Extremely anxious or depression

22 (6.4)

14 (4.5)

8 (4.8)

   

EQ-5D score (mean ± sd)

0.53 ± 0.28

0.59 ± 0.29

0.58 ± 0.28

0.001

0.020

0.721

EQ VAS (mean ± sd)

63.8 ± 21.9

68.7 ± 20.9

67.7 ± 21.5

0.001

0.010

0.628

  1. EQ-5D – EuroQol five Dimensions; EQ VAS – EuroQol visual analog scale; T0 – baseline evaluation; T1–1-year evaluation; T2–3-year evaluation. Ref. – reference. For category comparisons, some problems and extreme problems were grouped.